Vasoconstrictors in the Management of Bleeding from Oesophageal Varices a Clinico-Economic Appraisal in the UK

References

• Gimson A E, Westaby D. The management of an episode of variceal bleeding. Postgrad Med J 1991; 67: 140–6
   PubMed Web of Science ®Google Scholar
• Fleischer D. Etiology and prevalence of severe persistent upper gastrointestinal bleeding. Gastroenterology 1983; 84: 538–43
   PubMed Web of Science ®Google Scholar
• Management of acute variceal bleeding [editorial]. Lancet 1988; 2: 999–1000
   PubMed Web of Science ®Google Scholar
• Langman M JS. Upper gastrointestinal bleeding: the trials of trials. Gut 1985; 26: 217–20
   PubMed Web of Science ®Google Scholar
• Langman M JS. H2 antagonists in the treatment of upper gastrointestinal bleeding. Scand J Gastroenterol 1988; 23(Suppl 146)185–90
   Google Scholar
• Jenkins S A, Shield R S. Non-surgical management of the acute variceal bleed. Br J Surg 1992; 79: 859–60
   PubMed Web of Science ®Google Scholar
• Leicester R J. Gastrointestinal haemorrhage. Med Int 1990; 3188–91
   Google Scholar
• Raimes S A, Venables C W. Acute upper gastrointestinal bleeding. Hosp Update September, 1987; 669–84
   Google Scholar
• Madden M V, Griffith G H. Management of upper gastrointestinal bleeding in a district general hospital. J R Coll Physicians Lond 1986; 20: 212–5
   PubMedGoogle Scholar
• Analysis of Patient Management and Treatment Outcome Database. Dept. of Medicine, Royal Free Hospital, University of London, London 1992
   Google Scholar
• Walker S. Vasoconstrictor therapy in bleeding esophageal varices. Hepatogastroenterology 1990; 37: 538–43
   PubMedGoogle Scholar
• Hussey K P. Vasopressin therapy for upper gastrointestinal tract haemorrhage: has its efficacy been proven?. Arch Intern Med 1985; 145: 1263–7
   PubMedGoogle Scholar
• Conn H O. Vasopressin and nitroglycerin in the treatment of bleeding varices: the bottom line. Hepatology 1986; 6: 523–5
   PubMed Web of Science ®Google Scholar
• Merigan T C, Plotkin G R, Davidson C S. Effect of intravenously administered posterior pituitary extract on hemorrhage from bleeding esophageal varices. N Engl J Med 1962; 266: 134–5
   PubMed Web of Science ®Google Scholar
• Valenzuela J E, Schubert T, Fogel M R, Strong R M, Levine J, Mills P R, et al. A multicentre randomised, double-blind trial of somatostatin in the management of acute hemorrhage from esophageal varices. Hepatology 1989; 10: 958–61
   PubMed Web of Science ®Google Scholar
• Burroughs A K, McCormick P A, Hughes M D, Sprengers D, D'Heygere F, McIntyre N. Randomised, double-blind, placebo-controlled trial of somatostatin for variceal bleeding. Gastroenterology 1990; 99: 1388–95
   PubMed Web of Science ®Google Scholar
• Marshall J B. Bleeding esophagogastric varices. Ways to treat active episodes and prevent recurrence. Postgrad Med 1991; 89: 147–50; 155–8
   PubMed Web of Science ®Google Scholar
• Barsoum M S, Bolous F I, El-Rooby A A, Rizk-Allah M A, Ibrahim A S. Tamponade and injection sclerotherapy in the management of bleeding oesophageal varices. Br J Surg 1982; 69: 76–8
   PubMed Web of Science ®Google Scholar
• Paquet K J, Feussner H. Endoscopic sclerosis and esophageal balloon tamponade in acute hemorrhage from esophagogastric varices: a prospective controlled randomised trial. Hepatology 1985; 5: 580–3
   PubMed Web of Science ®Google Scholar
• Larson A, Cohen H, Zweiban B, Chapman D, Gourdji M, Korula J, et al. Acute esophageal variceal sclerotherapy: results of a prospective randomised controlled trial. JAMA 1986; 255: 497–500
   PubMed Web of Science ®Google Scholar
• Terblanche J, Yakoob H I, Bornman P C, Stiegmann G V, Bane R, Jonker M, et al. Acute bleeding varices: a five-year prospective evaluation of tamponade and sclerotherapy. Ann Surg 1981; 194: 521–30
   PubMed Web of Science ®Google Scholar
• Novis B H, Duys P, Barbezat G O, Clain J, Bank S, Terblanche J. Fibreoptic endoscopy and the use of the Sengstaken tube in acute gastrointestinal haemorrhage in patients with portal hypertension and varices. Gut 1976; 17: 258–63
   PubMed Web of Science ®Google Scholar
• Panes J, Teres J, Bosch J, Rodes J. Efficacy of balloon tamponade in the treatment of bleeding gastric and esophageal varices. Results in 151 consecutive episodes. Dig Dis Sci 1988; 33: 454–9
   PubMed Web of Science ®Google Scholar
• Graham D Y, Smith J L. The course of patients after variceal hemorrhage. Gastroenterology 1981; 80: 800–9
   PubMed Web of Science ®Google Scholar
• Burroughs A K, Mezzanotte G, Phillips A, McCormick P A, McIntyre N. Cirrhotics with variceal hemorrhage: the importance of the time interval between admission and the start of analysis for survival and rebleeding rates. Hepatology 1989; 9: 801–7
   PubMed Web of Science ®Google Scholar
• Chartered Institute of Public Finance & Accountancy and the Healthcare Financial Management Association. Health Database 1991. Health Service Trends. HFM: CIPFA, London 1992; Vol. 1, Financial analysis
   Google Scholar
• Royal College of Nursing of the United Kingdom. Nursing and midwifery staffs' pay scales from December. London 1991
   Google Scholar
• Appointments section. BMJ 1991; 301: 6819
   Google Scholar
• Drug Tariff. HMSO, London 1992
   Google Scholar
• British National Formulary. British Medical Association and Royal Pharmaceutical Society of Great Britain, London September, 1991; 22: 260
   Google Scholar
• Monthly Index of Medical Specialities (MIMS). 1991
   Google Scholar
• Conn H, Ramsby G, Storer E, Milton G, Mutchnick M D, Joshi P H, et al. Intra-arterial vasopressin in the treatment of upper gastrointestinal bleeding: a prospective, controlled clinical trial. Gastroenterology 1975; 68: 211–21
   PubMed Web of Science ®Google Scholar
• Mallory A, Schaefer J, Cohen J, Holt S, Norton L. Selective intra-arterial vasopressin infusion for upper gastro-intestinal tract hemorrhage. Arch Surg 1980; 115: 30–2
   PubMedGoogle Scholar
• Fogel M, Knauer M, Andres L L, Mahal A S, Stein D ET, Kemeny M J, et al. Continuous vasopressin in active upper gastro-intestinal bleeding. Ann Intern Med 1982; 96: 565–9
   PubMed Web of Science ®Google Scholar
• Freeman J, Lishman A, Cobden I, Record C. Controlled trial of terlipressin (glypressin) versus vasopressin in the early treatment of oesophageal varices. Lancet 1982; 2: 66–8
   PubMed Web of Science ®Google Scholar
• Kravetz D, Bosch J, Teres J, Bruix J, Rimola A, Rodes J. Comparison of intravenous somatostatin and vasopressin infusions in the treatment of acute variceal haemorrhage. Hepatology 1984; 4: 442–6
   PubMed Web of Science ®Google Scholar
• Tsai Y T, Lay C S, Lai K H, Ng W W, Yeh Y S, Wang J Y, et al. Controlled trial of vasopressin plus nitroglycerin versus vasopressin alone in the treatment of bleeding esophageal varices. Hepatology 1986; 6: 406–9
   PubMed Web of Science ®Google Scholar
• Gimson A ES, Westaby D, Hegarty J, Watson A, Williams R. A randomised trial of vasopressin and vasopressin plus nitroglycerin in the control of acute variceal haemorrhage. Hepatology 1986; 6: 410–3
   PubMed Web of Science ®Google Scholar
• Halpin J E, Tanner A R, Dellipiani A W. Endoscopic variceal sclerotherapy in a district general hospital: outcome and complications. Eur J Gastroenterol Hepatol 1992; 4: 1007–11
   Web of Science ®Google Scholar
• Devlin H B. Findings of the NCEPOD report for 1990. Br J Hosp Med 1992; 47(10)723–4
   PubMed Web of Science ®Google Scholar
• Working Team Report: Acute Variceal Rebleeding. World Congress of Gastroenterology, Athens. 1992
   Google Scholar
• Mastai R, Bosch J, Navasa M, Silva G, Kravetz D, Bruix J, et al. Effect of continuous infusion and bolus injections of somatostatin on azygous blood flow and hepatic and system haemodynamics in patients with portal hypertension. Comparison with vasopressin [abstract]. J Hepatol 1986; 3(Suppl 1)S53
   Google Scholar
• Burroughs A K. Somatostatin and octreotide for variceal bleeding. J Hepatol 1991; 13: 1–4
   PubMed Web of Science ®Google Scholar
• McCormick P A, Biagini M A, Dick R, Greenslade L, Chin J, Cardin F, et al. Octreotide inhibits the meal-induced increases in the portal venous pressure of cirrhotic patients with portal hypertension: a double-blind, placebo-controlled study. Hepatology 1992; 16: 1180–6
   PubMed Web of Science ®Google Scholar
• McCormick P A, Dick R, Siringo S, Wagstaff D, Chesta J, McIntyre N, et al. Octreotide reduces azygous blood flow in cirrhotic patients with portal hypertension. Eur J Gastroenterol Hepatol 1992; 4: 1007–11
   Google Scholar
• McKee R. A study of octreotide in oesophageal varices. Digestion 1990; 45(Suppl 1)60–5
   PubMed Web of Science ®Google Scholar
• Baxter J N, Jenkins S A, Shields R. SMS 201–995 and variceal haemorrhage. Acta Endocrinol (Copenh) 1987; 286: 37–44, Suppl
   Google Scholar
• Jenkins S A. Somatostatin in acute bleeding oesophageal varies. Drugs 1992; 44(Suppl 2)36–55
   PubMedGoogle Scholar